
Daily Target 2X Long MRNA ETF (MRNX) ETF Ticker
MRNX right now
Market factors today
Unlock the full MRNX picture
About Daily Target 2X Long MRNA ETF
The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). It achieves this primarily through the use of swap agreements and short-term listed call options. Its objective is to deliver a daily return equivalent to 200% (twice) the daily percentage change in MRNA's stock price, which it maintains through daily rebalancing. However, holding the fund for periods exceeding a single day may lead to actual returns that deviate significantly from this 2x daily target, influenced by factors like market volatility, compounding, and rebalancing impacts. For collateral supporting its derivative contracts, MRNX may also invest in stable assets such as U.S. government securities, money market funds, short-term bond exchange-traded funds (ETFs), and investment-grade corporate debt.
MRNX etf facts
| Ticker symbol | MRNX |
| Exchange | New York Stock Exchange Arca |
| Sector | Financial Services |
| Industry | Asset Management - Leveraged |
| Market cap | $6.2M |
| CEO | James Atkinson |
| Headquarters | Miami, FL, US |
| IPO date | 2026-02-04 |
| Website | www.defianceetfs.com/mrnx |
What you can see for MRNX on Tickr
Live MRNX price chart with overlays, holdings, sector and country allocation, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the MRNX report.
Rankings
FAQ
What is the ticker symbol for Daily Target 2X Long MRNA ETF?
The ticker symbol for Daily Target 2X Long MRNA ETF is MRNX, listed on the New York Stock Exchange Arca.
What is MRNX?
The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). It achieves this primarily through the use of swap agreements and short-term listed call options. Its objective is to deliver a daily return equivalent to 200% (twice) the daily percentage change in MRNA's stock price, which it maintains through daily…